Jacobs SA, Wang Y, Abraham J, Feng H, et al. Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer. Breast Cancer Res 2024;26:83.
PMID: 38790033